| ALUR |
ALLURION TECHNOLOGIES, INC. |
Common Stock, par value $0.0001 per share |
39% |
$8,542,574 |
|
5,891,430 |
0% |
RTW Investments, LP |
26 Feb 2026 |
| OBIO |
ORCHESTRA BIOMED HOLDINGS, INC. |
Common Stock, par value $0.0001 per share |
20% |
$49,561,068 |
+$15,090,906 |
11,942,426 |
+44% |
RTW Investments, LP |
23 Feb 2026 |
| ALUR |
ALLURION TECHNOLOGIES, INC. |
Common Stock, $0.0001 par value per share |
18% |
$451,523 |
|
1,050,053 |
0% |
RTW Investments, LP |
20 Feb 2025 |
| ESTA |
Establishment Labs Holdings Inc. |
Common Shares, No Par Value |
10% |
$84,073,815 |
|
2,822,216 |
|
RTW Investments, LP |
31 Dec 2024 |
| STOK |
Stoke Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
10% |
$50,498,414 |
|
5,310,033 |
|
RTW Investments, LP |
31 Dec 2024 |
| NGNE |
Neurogene Inc. |
Common Stock, par value $0.000001 per share |
10% |
$23,096,955 |
|
1,498,829 |
|
RTW Investments, LP |
31 Dec 2024 |
| VSTM |
Verastem, Inc. |
Common Stock, $0.0001 par value |
9.9% |
$60,496,591 |
+$17,057,672 |
7,836,346 |
+39% |
RTW Investments, LP |
31 Dec 2025 |
| CMPS |
COMPASS Pathways plc |
Ordinary Shares, par value GBP 0.008 per share |
9.9% |
$34,865,781 |
+$5,877,137 |
9,474,397 |
+20% |
RTW Investments, LP |
30 Jun 2025 |
| MIST |
MILESTONE PHARMACEUTICALS INC. |
Common Shares, no par value per share |
9.9% |
$18,310,336 |
+$7,029,150 |
9,155,168 |
+62% |
RTW Investments, LP |
30 Sep 2025 |
| TENX |
Tenax Therapeutics, Inc. |
Common Stock, $0.0001 par value |
9.9% |
$9,797,068 |
+$3,499,546 |
650,968 |
+56% |
RTW Investments, LP |
31 Dec 2025 |
| GHRS |
GH Research PLC |
Ordinary shares, nominal value $0.025 per share |
8.9% |
$52,412,799 |
|
5,499,769 |
|
RTW Investments, LP |
31 Mar 2025 |
| RAPT |
Rapt Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
8.9% |
$10,234,680 |
|
11,764,000 |
|
RTW Investments, LP |
31 Mar 2025 |
| XNCR |
Xencor Inc |
Common Stock, $0.01 par value |
8.7% |
$72,972,963 |
|
6,221,054 |
|
RTW Investments, LP |
30 Sep 2025 |
| IMTX |
Immatics N.V. |
Ordinary Shares, nominal value (euro) 0.01 per share |
8.5% |
$120,050,217 |
+$27,486,238 |
11,433,354 |
+30% |
RTW Investments, LP |
31 Dec 2025 |
| TSHA |
TAYSHA GENE THERAPIES, INC. |
Common Stock, par value $0.00001 per share |
8.3% |
$120,312,664 |
-$9,129,432 |
23,407,133 |
-7.1% |
RTW Investments, LP |
31 Dec 2025 |
| REPL |
Replimune Group, Inc. |
Common Stock, $0.001 par value |
8.2% |
$26,798,117 |
|
6,395,732 |
|
RTW Investments, LP |
30 Sep 2025 |
| PTGX |
Protagonist Therapeutics, Inc |
Common Stock, $0.00001 par value |
8.1% |
$405,989,003 |
|
5,059,053 |
|
RTW Investments, LP |
31 Dec 2025 |
| TARS |
Tarsus Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
8.1% |
$134,159,372 |
|
3,424,180 |
|
RTW Investments, LP |
30 Jun 2025 |
| CSTL |
CASTLE BIOSCIENCES, INC. |
Common Stock, $0.001 par value |
7.2% |
$84,757,547 |
|
2,115,237 |
|
RTW Investments, LP |
31 Dec 2025 |
| ZLAB |
Zai Lab Limited |
Ordinary Shares, par value $0.000006 per share |
6.3% |
$1,258,888,889 |
+$844,379,694 |
69,590,320 |
+204% |
RTW Investments, LP |
31 Dec 2025 |
| SYRE |
Spyre Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
6.2% |
$54,402,380 |
|
3,621,996 |
|
RTW Investments, LP |
31 Dec 2024 |
| APLS |
Apellis Pharmaceuticals, Inc. |
Common Stock, $0.0001 par value |
6.1% |
$163,532,076 |
|
7,666,764 |
|
RTW Investments, LP |
31 Dec 2025 |
| QURE |
uniQure N.V. |
Ordinary Shares, par value 0.05 euro |
6% |
$86,811,096 |
-$16,688,905 |
3,711,462 |
-16% |
RTW Investments, LP |
31 Dec 2025 |
| RAPT |
RAPT THERAPEUTICS, INC. |
Common Stock, $0.0001 par value |
5.9% |
$55,041,487 |
|
1,637,165 |
|
RTW Investments, LP |
31 Dec 2025 |
| BBNX |
BETA BIONICS, INC. |
Common Stock, $0.0001 par value |
5.7% |
$50,350,000 |
-$16,109,362 |
2,500,000 |
-24% |
RTW Investments, LP |
31 Dec 2025 |
| KLRS |
KALARIS THERAPEUTICS, INC. |
Common Stock, $0.0001 par value |
5.7% |
$12,714,000 |
|
1,300,000 |
|
RTW Investments, LP |
31 Dec 2025 |
| AQST |
Aquestive Therapeutics, Inc. |
Common Stock, $0.001 par value |
5.2% |
$34,937,500 |
|
6,250,000 |
|
RTW Investments, LP |
30 Sep 2025 |
| RDNT |
RadNet, Inc. |
Common Stock, $0.0001 par value |
5.1% |
$300,704,475 |
|
3,938,500 |
|
RTW Investments, LP |
31 Dec 2025 |
| APGE |
APOGEE THERAPEUTICS, INC. |
Common Stock, $0.00001 par value |
4.9% |
$214,255,663 |
|
2,712,097 |
0% |
RTW Investments, LP |
31 Dec 2025 |
| SAGE |
Sage Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
4.9% |
$23,388,462 |
|
3,002,370 |
|
RTW Investments, LP |
31 Dec 2024 |
| XGN |
Exagen Inc. |
Common Stock, par value $0.001 per share |
4.9% |
$6,984,509 |
-$3,332,436 |
1,148,768 |
-32% |
RTW Investments, LP |
31 Dec 2025 |
| ORKA |
ORUKA THERAPEUTICS, INC. |
Common Stock, $0.001 par value |
4.3% |
$62,382,466 |
+$3,409,845 |
2,058,148 |
+5.8% |
RTW Investments, LP |
31 Dec 2025 |
| ACAD |
ACADIA PHARMACEUTICALS INC. |
Common Stock, $0.0001 par value |
4.2% |
$152,464,142 |
-$33,311,249 |
7,144,524 |
-18% |
RTW Investments, LP |
30 Sep 2025 |
| SABS |
SAB Biotherapeutics, Inc. |
Common Stock, $0.0001 par value |
3.2% |
$6,253,970 |
+$2,218,090 |
1,587,302 |
+55% |
RTW Investments, LP |
31 Dec 2025 |
| RNA |
Avidity Biosciences, Inc. |
Common Stock, par value $0.0001 per share |
3.1% |
$204,173,813 |
|
4,686,110 |
|
RTW Investments, LP |
27 Oct 2025 |
| AXSM |
Axsome Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
3.1% |
$165,312,089 |
-$153,206,917 |
1,516,903 |
-48% |
RTW Investments, LP |
30 Jun 2025 |
| MRUS |
Merus N.V. |
Common Shares, nominal value (euro) 0.09 per share |
2.7% |
$190,679,830 |
|
2,025,277 |
|
RTW Investments, LP |
30 Sep 2025 |
| EPIX |
ESSA Pharma Inc. |
Common Shares, no par value |
2.5% |
$2,003,404 |
|
1,113,002 |
|
RTW Investments, LP |
31 Dec 2024 |
| DYN |
Dyne Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
1.5% |
$18,782,199 |
-$39,196,902 |
1,690,567 |
-68% |
RTW Investments, LP |
31 Mar 2025 |
| ETNB |
89bio, Inc. |
Common Stock, par value $0.001 per share |
1.3% |
$13,575,936 |
|
1,967,527 |
|
RTW Investments, LP |
31 Mar 2025 |
| IMUX |
Immunic, Inc. |
Common Stock, par value $0.0001 per share |
1.1% |
$1,170,509 |
|
1,026,762 |
|
RTW Investments, LP |
31 Mar 2025 |
| CUTRQ |
Cutera, Inc. |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
RTW Investments, LP |
31 Dec 2024 |
| GERN |
Geron Corporation |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
RTW Investments, LP |
31 Dec 2024 |
| PEPG |
PepGen Inc. |
Common Stock, $0.0001 par value per share |
0% |
$0 |
-$5,108,955 |
0 |
-100% |
RTW Investments, LP |
31 Mar 2025 |
| CRGX |
CARGO THERAPEUTICS, INC. |
Common stock, par value $0.001 per share |
0% |
$0 |
-$13,656,132 |
0 |
-100% |
RTW Investments, LP |
30 Sep 2025 |
| AKRO |
Akero Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
0% |
$0 |
-$238,651,886 |
0 |
-100% |
RTW Investments, LP |
31 Dec 2025 |
| ALEC |
Alector, Inc. |
Common Stock, $0.0001 par value |
0% |
$0 |
-$13,002,899 |
0 |
-100% |
RTW Investments, LP |
31 Dec 2025 |